AC Immune SA (ACIU) [Rocket]

Overview

AC Immune SA (ACIU)

Add to portfolio

Recent News + Filings (All items)

Date Filed	Type	Description
08/22/2023	144	Form 144 - Report of proposed sale of securities:
08/21/2023	144	Form 144 - Report of proposed sale of securities:
08/17/2023	144	Form 144 - Report of proposed sale of securities:
08/09/2023	144	Form 144 - Report of proposed sale of securities:
08/08/2023	144	Form 144 - Report of proposed sale of securities:
08/04/2023	6-K	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
07/26/2023	6-K	Quarterly results

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
Revenues	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Revenue growth								-100.0%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross margin
Selling, general and administrative	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Research and development
EBIT	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EBIT margin
Pre-tax income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate
Net income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net margin


EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy